Pablo Zubiaur

1.8k total citations
73 papers, 877 citations indexed

About

Pablo Zubiaur is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Pablo Zubiaur has authored 73 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pharmacology, 19 papers in Pediatrics, Perinatology and Child Health and 17 papers in Oncology. Recurrent topics in Pablo Zubiaur's work include Pharmacogenetics and Drug Metabolism (33 papers), Drug Transport and Resistance Mechanisms (13 papers) and Pharmaceutical studies and practices (9 papers). Pablo Zubiaur is often cited by papers focused on Pharmacogenetics and Drug Metabolism (33 papers), Drug Transport and Resistance Mechanisms (13 papers) and Pharmaceutical studies and practices (9 papers). Pablo Zubiaur collaborates with scholars based in Spain, United States and Tunisia. Pablo Zubiaur's co-authors include Francisco Abad‐Santos, Dóra Koller, Miriam Saiz‐Rodríguez, Gina Mejía‐Abril, Dolores Ochoa, Manuel Román, Marcos Navares‐Gómez, Aneta Wojnicz, Carmen Belmonte and Alberto M. Borobia and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Pablo Zubiaur

66 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pablo Zubiaur Spain	17	332	171	164	161	130	73	877
Miriam Saiz‐Rodríguez Spain	19	351 1.1×	166 1.0×	176 1.1×	191 1.2×	183 1.4×	58	984
Gina Mejía‐Abril Spain	15	259 0.8×	105 0.6×	128 0.8×	123 0.8×	108 0.8×	49	647
Mila Lovrić Croatia	16	269 0.8×	165 1.0×	211 1.3×	162 1.0×	211 1.6×	48	842
Manoranjenni Chetty United Kingdom	18	217 0.7×	141 0.8×	179 1.1×	221 1.4×	205 1.6×	41	953
Dolores Ochoa Spain	25	548 1.7×	301 1.8×	273 1.7×	207 1.3×	251 1.9×	98	1.6k
Junji Saruwatari Japan	22	244 0.7×	249 1.5×	220 1.3×	259 1.6×	131 1.0×	108	1.4k
Géraldine M. Ferron United States	19	278 0.8×	138 0.8×	210 1.3×	303 1.9×	231 1.8×	28	1.1k
Venkatesh Pilla Reddy United States	19	207 0.6×	118 0.7×	130 0.8×	325 2.0×	305 2.3×	56	1.1k
Séverine Crettol Switzerland	18	586 1.8×	253 1.5×	454 2.8×	289 1.8×	286 2.2×	40	1.5k
Andria L. Del Tredici United States	14	457 1.4×	56 0.3×	203 1.2×	191 1.2×	109 0.8×	28	835

Countries citing papers authored by Pablo Zubiaur

Since Specialization

Citations

This map shows the geographic impact of Pablo Zubiaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Zubiaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Zubiaur more than expected).

Fields of papers citing papers by Pablo Zubiaur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Zubiaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Zubiaur. The network helps show where Pablo Zubiaur may publish in the future.

Co-authorship network of co-authors of Pablo Zubiaur

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Zubiaur. A scholar is included among the top collaborators of Pablo Zubiaur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Zubiaur. Pablo Zubiaur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lubomirov, Rubin, et al.. (2025). CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin. Clinical and Translational Science. 18(4). e70173–e70173.

Falcón, Alejandro, Santiago Ponce, Gregory M. Coté, et al.. (2025). Phase I results on the efficacy, safety and pharmacokinetics of lurbinectedin and irinotecan in advanced solid tumors. Investigational New Drugs. 43(4). 955–967.

Omezzine, Asma, et al.. (2025). Impact of Genetic Variation in Adrenergic Receptors on β-Blocker Effectiveness and Safety in Cardiovascular Disease Management: A Systematic Review. Pharmaceuticals. 18(4). 493–493.

Eadon, Michael T., David W. Hein, Michael Asger Andersen, et al.. (2025). Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy. Clinical Pharmacology & Therapeutics. 118(6). 1430–1436.

Zubiaur, Pablo, et al.. (2024). SLCO1B1 and ABCG2 genotype‐informed phenotypes are related to variation in ramipril exposure. Basic & Clinical Pharmacology & Toxicology. 135(3). 295–307. 1 indexed citations

Eum, Seenae, Zeruesenay Desta, Rachel F. Tyndale, et al.. (2024). Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy. Clinical Pharmacology & Therapeutics. 116(4). 932–938. 9 indexed citations

Navares‐Gómez, Marcos, Francisca Molina‐Jiménez, Emilio J. Laserna‐Mendieta, et al.. (2024). Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis. International Journal of Molecular Sciences. 25(7). 3685–3685. 4 indexed citations

Zubiaur, Pablo, Erin C. Boone, Jean Dinh, et al.. (2023). Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro Activity. Clinical Pharmacology & Therapeutics. 114(5). 1033–1042. 9 indexed citations

Zubiaur, Pablo, Miriam Saiz‐Rodríguez, Marcos Navares‐Gómez, et al.. (2023). Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post‐surgical pain. Clinical and Translational Science. 17(1). e13698–e13698.

10.

Saiz‐Rodríguez, Miriam, Dolores Ochoa, Pablo Zubiaur, et al.. (2023). Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of Personalized Medicine. 13(3). 489–489. 9 indexed citations

11.

Zubiaur, Pablo, et al.. (2023). Preemptive TPMT Genotyping and Adherence to Genotype-Based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-Mercaptopurine for Autoimmune Diseases. Journal of Personalized Medicine. 13(8). 1208–1208. 5 indexed citations

12.

Villatoro, Jaime Monserrat, Gina Mejía‐Abril, Pablo Zubiaur, et al.. (2022). A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis. Pharmaceuticals. 15(1). 78–78. 5 indexed citations

13.

Würthwein, Gudrun, Pablo Zubiaur, Bianca Posocco, et al.. (2022). Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mg. Cancer Chemotherapy and Pharmacology. 90(2). 125–136. 4 indexed citations

14.

Zubiaur, Pablo, Elena Fernández‐Ruiz, Isidoro González‐Álvaro, et al.. (2022). Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity. Life Science Alliance. 5(10). e202201396–e202201396. 4 indexed citations

15.

Vázquez, Patricia, Eva Tudurí, Mercedes Mirasierra, et al.. (2021). The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice. Diabetologia. 65(3). 490–505. 11 indexed citations

16.

Mejía‐Abril, Gina, Pablo Zubiaur, Marcos Navares‐Gómez, et al.. (2021). Dexketoprofen Pharmacokinetics is not Significantly Altered by Genetic Polymorphism. Frontiers in Pharmacology. 12. 660639–660639. 5 indexed citations

17.

Zubiaur, Pablo, Dolores Ochoa, Gina Mejía‐Abril, et al.. (2021). ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics. Biomedicine & Pharmacotherapy. 142. 112083–112083. 6 indexed citations

18.

Zubiaur, Pablo, Dolores Ochoa, Miriam Saiz‐Rodríguez, et al.. (2019). Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally. Advances in Therapy. 36(10). 2744–2755. 4 indexed citations

19.

Koller, Dóra, Carmen Belmonte, Rubin Lubomirov, et al.. (2018). Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects. Journal of Psychopharmacology. 32(11). 1212–1222. 13 indexed citations

20.

Zubiaur, Pablo, et al.. (1977). Effect of levamisole on carrageenin-induced foot edema of normal and adrenalectomized rats.. PubMed. 32(10). 512–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact